ANVISA - Brazil completes inspection at Caplin Steriles' facility at Gummidipoondi

ANVISA - Brazil conducted an inspection of Caplin Steriles' injectable and ophthalmic manufacturing facility located at Gummidipoondi. The inspection was conducted between August 12th and 16th, 2024 and concluded with zero observations.

Chairman Mr.C.C.Paarthipan added "It is indeed gratifying to have two back to back audits with Zero observations. We remain steadfast in our commitment to maintaining the highest levels of quality compliance at all our sites. Brazil is an important part of our expansion plans in Latin America and this clearance opens the door to the largest market in that geography."

Shares of Caplin Point Laboratories Limited was last trading in BSE at Rs. 1585.75 as compared to the previous close of Rs. 1559.60. The total number of shares traded during the day was 12416 in over 1193 trades.

The stock hit an intraday high of Rs. 1597.00 and intraday low of 1563.00. The net turnover during the day was Rs. 19650281.00.

Source : Equity Bulls

Keywords

CaplinPointLaboratories INE475E01026 CaplinSteriles Inspection ANVISA Brazil Gummidipoondi ManufacturingFacility ZeroObservations